---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-278827"
form_type: "8-K"
ticker: "CNTA"
cik: "0001847903"
company_name: "Centessa Pharmaceuticals plc"
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:33:42.246823+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Centessa prices $250M public offering of 11.6M ADSs at $21.50 per ADS

## Summary
- Priced 11,627,907 ADSs at $21.50 each; gross proceeds ~$250M; net proceeds ~$234.4M.
- Underwriters granted 30-day option to purchase up to 1,744,186 additional ADSs.
- Offering expected to close November 14, 2025; proceeds to fund product development and general corporate purposes.
- Existing cash plus net proceeds expected to fund operating expenses into 2028.
- Jefferies, Leerink Partners, Evercore ISI, and Guggenheim Securities are joint book-running managers.

## SEC filing metadata
- accession: 0001193125-25-278827
- form_type: 8-K
- ticker: CNTA
- cik: 0001847903
- company_name: Centessa Pharmaceuticals plc
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847903/000119312525278827/0001193125-25-278827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847903/000119312525278827/d39112d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-278827
- JSON: https://secwatch.observer/filing/0001193125-25-278827.json
- Plain text: https://secwatch.observer/filing/0001193125-25-278827.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.